This statistic displays the projected distribution of cost-sharing for brand name drugs in the Medicare Part D coverage gap in the United States from 2016 to 2020. In 2016, five percent of the cost of brand name drugs is expected to be paid by CMS. Provisions of the Affordable Care Act mandate the gradual closure of the Medicare Part D coverage gap through pharmaceutical manufacturer discounts and CMS subsidies.
Cost sharing for branded drugs in the Medicare Part D coverage gap from 2016 to 2020
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Medicare Part D payer share of branded and generic drugs by therapy area 2015
- Share of generic drug costs in Medicare Part D gap in the U.S. 2016-2020
- Payer share of Medicare Part D retail prescriptions by therapy class 2018
- Medicare's costliest drugs 2015
- Medicare hospital inpatient charges by disease in the U.S. 2017
- Medicare inpatient hospital ALOS in U.S. cases by disease and IDN status 2016
- Medicare hospital inpatient case charges by severity in the U.S. 2014
- Sales volume percentage change of leading brand name drugs in Italy 2019/2020
- Name-brand versus store brand: U.S. consumers' purchase preferences of OTC drugs 2014
- Managed Care percentage in the U.S. of total Medicare spending 2007-2019
- Total Medicare Advantage enrollment in the U.S. 2004-2021
- Number of Medicare Advantage plans 2010-2022, by plan type
- Medicare reimbursements of inpatient charges in the U.S. by condition 2019
- Leading U.S. not-for-profit hospitals by Medicare patient charges 2016
- Rates of Medicare acceptance in select U.S. metropolitan areas by specialty 2013
- Share of hospitals penalized by Medicare for high readmission rates U.S. 2013-2017
- Medicare - number of general hospital facilities in the U.S. 1967-2014
- Monthly change in Medicare enrollment U.S. 2019-2020
- Importance of sustainability for consumers when choosing a brand India 2020
Sanofi. (December 20, 2016). Cost sharing for branded drugs in the Medicare Part D coverage gap from 2016 to 2020 [Graph]. In Statista. Retrieved July 06, 2022, from https://www.statista.com/statistics/320731/distribution-of-brand-name-drug-costs-in-medicare-part-d-coverage-gap/
Sanofi. "Cost sharing for branded drugs in the Medicare Part D coverage gap from 2016 to 2020." Chart. December 20, 2016. Statista. Accessed July 06, 2022. https://www.statista.com/statistics/320731/distribution-of-brand-name-drug-costs-in-medicare-part-d-coverage-gap/
Sanofi. (2016). Cost sharing for branded drugs in the Medicare Part D coverage gap from 2016 to 2020. Statista. Statista Inc.. Accessed: July 06, 2022. https://www.statista.com/statistics/320731/distribution-of-brand-name-drug-costs-in-medicare-part-d-coverage-gap/
Sanofi. "Cost Sharing for Branded Drugs in The Medicare Part D Coverage Gap from 2016 to 2020." Statista, Statista Inc., 20 Dec 2016, https://www.statista.com/statistics/320731/distribution-of-brand-name-drug-costs-in-medicare-part-d-coverage-gap/
Sanofi, Cost sharing for branded drugs in the Medicare Part D coverage gap from 2016 to 2020 Statista, https://www.statista.com/statistics/320731/distribution-of-brand-name-drug-costs-in-medicare-part-d-coverage-gap/ (last visited July 06, 2022)